Related Experiment Videos
Remote effects of inflammation on non-specific immunity
R M Fauve1, E Fontan, M B Hevin
1Unité d'Immunophysiologie cellulaire de l'Institut Pasteur, Paris, France.
Immunology Letters
|December 1, 1987
Summary
Inflammation enhances host resistance against infections and tumors by stimulating immune cells. This study identifies key proteins involved in this enhanced resistance, offering potential therapeutic targets.
Area of Science:
- Immunology
- Cell Biology
- Biochemistry
Background:
- Inflammation can non-specifically enhance host resistance against various challenges.
- This phenomenon occurs even in immune-compromised animal models.
- The underlying molecular mechanisms require further elucidation.
Purpose of the Study:
- To investigate the molecular basis of inflammation-induced host resistance.
- To identify proteins responsible for enhanced immune cell activity.
- To explore the potential of these proteins in immunotherapy.
Main Methods:
- Induction of inflammation in mice using inert substances.
- Analysis of immune cell responses, including leukopoiesis and macrophage activation.
- Protein isolation and characterization (MW, pI) from inflammatory sites and serum.
- In vitro and in vivo assays to assess protein function and efficacy against pathogens and tumor cells.
Main Results:
- Inflammation led to increased leukopoiesis via a 40 kDa protein inducing polymorph differentiation.
- Giant cells in granulomas released an immunostimulatory protein activating macrophages.
- A distinct 56 kDa heat-labile protein activated liver and spleen macrophages, conferring protection against Listeria monocytogenes and activating macrophages against tumor cells.
- This 56 kDa protein is distinct from TNF and GM-CSF and shows cross-species activity.
Conclusions:
- Inflammation triggers complex molecular events enhancing host defense mechanisms.
- Specific proteins isolated from inflammatory sites and serum play crucial roles in immune activation.
- These identified proteins represent promising candidates for novel immunotherapeutic strategies against infections and cancer.